Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Houston, TX
NPI
1558707711
Since 2013
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6701 Fannin St Ste 1250
Houston, TX, 77030
Phone (832) 822-1779
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.0M
188 prescriptions
Company payments, 2025
$1,558
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Davut Pehlivan prescribed most often to Medicare patients was Daybue (Trofinetide), with 37 prescriptions and refills. In total Davut Pehlivan wrote 188 Medicare prescriptions that cost $2.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Daybue Trofinetide | 37 | 37 | Under 11 | $1.9M |
| Clobazam Generic | 32 | 32 | Under 11 | $4,080 |
| Levetiracetam Generic | 20 | 24 | Under 11 | $475 |
| Lamotrigine Generic | 19 | 29 | Under 11 | $683 |
| Trazodone Hcl Generic | 15 | 15 | Under 11 | $49.09 |
| Keppra Levetiracetam | 12 | 12 | Under 11 | $23K |
Brand drugs: 54 claims; generic drugs: 134 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Davut Pehlivan $1,558 ($1,558 in general payments such as food, travel and fees) from 2 companies. The largest payer was Ionis Pharmaceuticals, Inc. with $1,515.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.